ArticleAmerican journal of hematology2025

Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High-Risk Subtype That Warrants an Independent Prognostic Designation.

Jayastu Senapati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.